Product Reports Resources Pricing Login Book a demo

Injective

Fintech · New York City, United States · Founded 2018

The blockchain built for finance

Valuation $100–500M
Revenue $10–50M
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Injective and the history behind them.
Power Law Colt$25–100M revenue

Talent graph

Injective's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

28 investors on Injective's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 11 investors entered at this stage
Krypital Group
QCP Soteria
Cadenza
BitScale
The Cabin Capital
Innovating Capital
Axia8 Ventures
Pantera Capital
AU21 Capital
PNYX Venture
StartX
Series A 15 investors entered at this stage
Jump Crypto
GFS Ventures
Evangelion Capital
Infinity Capital
Mark Cuban Companies
Ellipti
GravityX Capital
ZBS CAPITAL
White Palm Ventures
QCP Capital
Black Edge Capital
Black Mamba Ventures
BlockTower Capital
CMS Holdings
#Hashed
Series B+ 2 investors entered at this stage
Brevan Howard Digital
Mark Cuban

Global footprint

Where Injective has talent and traffic

Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown
Web traffic by country
57K monthly visits
across markets
🇺🇸 United States10.2%
🇪🇸 Spain9.8%
🏳️ Korea7%
🏳️ Republic of6.3%
🇳🇬 Nigeria6.1%
Top 5 markets shown

Capital deployed

Injective's 4 investments and acquisitions.

Every disclosed deal where Injective appeared as a backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Injective's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Injective's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Injective

        An AI-synthesized read of the highest-engagement posts about Injective on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Injective on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles